Walgreens, Teva face San Francisco trial over opioid epidemic | Business Insurance
Israeli unions warn Teva Pharm over plan to close Ashdod plant
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NTZR6T726RLT7GRNRNBROU2NCQ.jpg "US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters")
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva rejects Israeli PM's request to keep Jerusalem plant open | Reuters
Drugmaker Teva hires Lundbeck CEO Schultz to restore its health | Reuters
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Politicians can decry Teva layoffs, but why did they give billions in tax breaks? - Israel News - The Jerusalem Post
Exclusive: Teva poised to raise its stake in Mylan - sources
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
GSK's $235 million verdict revived against Teva, again | Reuters
Teva Pharmaceutical Industries Ltd | Reuters
Teva Pharmaceutical Is in Recovery - WSJ
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report
Teva to Acquire Mexico's Rimsa for $2.3 Billion - WSJ
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Teva enters billion-dollar settlement in US opioid case — MedWatch
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva settles shareholder lawsuit over generic drug | Business Insurance
Drug-maker Teva fueled opioid addiction in NY, jury finds | Business Insurance
Teva Pharm to lay off a quarter of workforce, suspends dividend | Reuters
